# CorMedix Inc.: filings

CRMD · Nasdaq · CIK 1410098 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/crmd.md) · [Financials](/companies/crmd/financials.md) · [Filings](/companies/crmd/filings.md) · [Insiders](/companies/crmd/insiders.md)

## Reports and events: 411 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 439, 8-K 290, 10-Q 50, 3 40, 4/A 28, 424B5 21, DEF 14A 21, DEFA14A 18, 10-K 16, EFFECT 16, 144 15, S-3 13, CORRESP 12, SC 13G 12, UPLOAD 12, SC 13D/A 10, CT ORDER 9, SC 13G/A 9, PRE 14A 8, 10-Q/A 7, 424B3 7, SCHEDULE 13G/A 7, 10-K/A 6, S-8 6, POS AM 5, S-3/A 5, 8-K/A 4, RW 4, S-1/A 4, 3/A 3, ARS 3, 25-NSE 2, 424B1 2, 424B4 2, 8-A12B 2, D 2, FWP 2, S-3ASR 2, SC 13D 2, SCHEDULE 13G 2, 25 1, CERT 1, CERTNYS 1, NT 10-Q 1, PRER14A 1, S-1 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 12:00 ET | [8-K](/filings/0001213900-26-110477.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-110477 |
| 2026-08-13 | 12:07 ET | [10-Q](/filings/0001410098-26-000056.md) | Quarterly report, period 2026-06-30 | 0001410098-26-000056 |
| 2026-08-13 | 11:32 ET | [8-K](/filings/0001410098-26-000054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001410098-26-000054 |
| 2026-08-07 | 20:18 ET | [8-K](/filings/0001410098-26-000044.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001410098-26-000044 |
| 2026-07-02 | 20:30 ET | [8-K](/filings/0001410098-26-000040.md) | 8.01 Other events | 0001410098-26-000040 |
| 2026-07-01 | 11:14 ET | [8-K](/filings/0001410098-26-000037.md) | 4.01 Change of auditor | 0001410098-26-000037 |
| 2026-06-24 | 20:30 ET | [8-K](/filings/0001410098-26-000028.md) | 5.07 Shareholder vote results | 0001410098-26-000028 |
| 2026-06-08 | 12:45 ET | [8-K](/filings/0001213900-26-066061.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-066061 |
| 2026-05-14 | 12:00 ET | [10-Q](/filings/0001410098-26-000021.md) | Quarterly report, period 2026-03-31 | 0001410098-26-000021 |
| 2026-05-14 | 11:34 ET | [8-K](/filings/0001410098-26-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001410098-26-000020 |
| 2026-04-29 | 20:16 ET | [DEF 14A](/filings/0001213900-26-049311.md) | Proxy statement, period 2026-06-23 | 0001213900-26-049311 |
| 2026-04-27 | 12:05 ET | [8-K](/filings/0001213900-26-047748.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-047748 |
| 2026-03-06 | 22:07 ET | [8-K](/filings/0001213900-26-024777.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-024777 |
| 2026-03-05 | 13:32 ET | [10-K](/filings/0001213900-26-023889.md) | Annual report, period 2025-12-31 | 0001213900-26-023889 |
| 2026-03-05 | 12:47 ET | [8-K](/filings/0001213900-26-023881.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-023881 |
| 2026-01-08 | 13:15 ET | [8-K](/filings/0001213900-26-002350.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-002350 |
| 2025-11-12 | 13:21 ET | [10-Q](/filings/0001213900-25-108777.md) | Quarterly report, period 2025-09-30 | 0001213900-25-108777 |
| 2025-11-12 | 12:42 ET | [8-K](/filings/0001213900-25-108716.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-108716 |
| 2025-10-24 | 12:21 ET | [DEF 14A](/filings/0001213900-25-101906.md) | Proxy statement, period 2025-11-10 | 0001213900-25-101906 |
| 2025-10-20 | 12:10 ET | [8-K](/filings/0001213900-25-100156.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-100156 |
| 2025-09-30 | 20:30 ET | [8-K/A](/filings/0001213900-25-093983.md) | 9.01 Financial statements and exhibits | 0001213900-25-093983 |
| 2025-09-02 | 12:57 ET | [8-K](/filings/0001213900-25-082956.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-082956 |
| 2025-08-12 | 20:43 ET | [8-K](/filings/0001213900-25-075010.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-075010 |
| 2025-08-07 | 12:51 ET | [10-Q](/filings/0001213900-25-072843.md) | Quarterly report, period 2025-06-30 | 0001213900-25-072843 |
| 2025-08-07 | 11:31 ET | [8-K](/filings/0001213900-25-072814.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-072814 |
| 2025-06-30 | 20:44 ET | [8-K](/filings/0001213900-25-059702.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-059702 |
| 2025-06-25 | 10:07 ET | [8-K](/filings/0001213900-25-057451.md) | 5.07 Shareholder vote results | 0001213900-25-057451 |
| 2025-06-23 | 11:51 ET | [8-K](/filings/0001213900-25-056415.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-056415 |
| 2025-05-06 | 12:32 ET | [10-Q](/filings/0001213900-25-039908.md) | Quarterly report, period 2025-03-31 | 0001213900-25-039908 |
| 2025-05-06 | 11:45 ET | [8-K](/filings/0001213900-25-039903.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-039903 |
| 2025-04-28 | 20:30 ET | [DEF 14A](/filings/0001213900-25-036108.md) | Proxy statement, period 2025-06-24 | 0001213900-25-036108 |
| 2025-04-22 | 20:30 ET | [8-K](/filings/0001213900-25-034219.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-034219 |
| 2025-04-08 | 12:00 ET | [8-K](/filings/0001213900-25-029629.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-029629 |
| 2025-03-25 | 12:30 ET | [10-K](/filings/0001013762-25-001852.md) | Annual report, period 2024-12-31 | 0001013762-25-001852 |
| 2025-03-25 | 12:00 ET | [8-K](/filings/0001013762-25-001844.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001013762-25-001844 |
| 2025-01-07 | 13:00 ET | [8-K](/filings/0001213900-25-001392.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-001392 |
| 2024-11-25 | 21:15 ET | [8-K](/filings/0001213900-24-102170.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-24-102170 |
| 2024-10-30 | 12:20 ET | [10-Q](/filings/0001213900-24-091961.md) | Quarterly report, period 2024-09-30 | 0001213900-24-091961 |
| 2024-10-30 | 12:00 ET | [8-K](/filings/0001213900-24-091959.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-091959 |
| 2024-10-08 | 20:56 ET | [DEF 14A](/filings/0001213900-24-086301.md) | Proxy statement, period 2024-11-21 | 0001213900-24-086301 |
| 2024-08-14 | 12:15 ET | [10-Q](/filings/0001213900-24-068600.md) | Quarterly report, period 2024-06-30 | 0001213900-24-068600 |
| 2024-08-14 | 12:00 ET | [8-K](/filings/0001213900-24-068589.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-068589 |
| 2024-05-09 | 12:00 ET | [10-Q](/filings/0001213900-24-041031.md) | Quarterly report, period 2024-03-31 | 0001213900-24-041031 |
| 2024-05-09 | 11:40 ET | [8-K](/filings/0001213900-24-041026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-041026 |
| 2024-03-12 | 12:15 ET | [10-K](/filings/0001213900-24-021585.md) | Annual report, period 2023-12-31 | 0001213900-24-021585 |
| 2024-03-12 | 11:35 ET | [8-K](/filings/0001213900-24-021573.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-021573 |
| 2024-01-30 | 22:26 ET | [8-K](/filings/0001213900-24-008015.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-008015 |
| 2023-12-15 | 13:39 ET | [8-K](/filings/0001213900-23-095909.md) | 5.02 Departure or appointment of officers or directors | 0001213900-23-095909 |
| 2023-11-16 | 21:11 ET | [8-K](/filings/0001213900-23-087921.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-23-087921 |
| 2023-11-14 | 21:20 ET | [10-Q](/filings/0001213900-23-086981.md) | Quarterly report, period 2023-09-30 | 0001213900-23-086981 |

Page 1 of 9. [Older](/companies/crmd/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.